Articles

Atrial fibrillation (AF) is a precursor to a number of serious cardiovascular complications, including stroke. The increasing prevalence and cost of treating these cardiovascular complications has...

In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment – including events ranging from the 2006 BASKET-LATE trial that caused a tremendous...

The incidence of cardiac arrhythmia is expected to increase significantly with an aging U.S. population and rising rates of obesity. In 2008, atrial fibrillation (AF), the most common complex...

The practice of cardiac catheter ablation may experience a big boost as catheter ablation systems are poised to be indicated for the treatment of atrial fibrillation (AFib).

February 9, 2009 - Biosense Webster Inc. said Friday the FDA granted market clearance for the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal...

When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose pumping power is weaker than normal, physicians are facing a paradox.

Ah, money, money, money — the Frankenstein monster that destroys souls.”
It’s one of many oddball lines from the zany 1930s Carole Lombard and William Powell comedy, “My Man Godfrey,” but it...